The Active ingredient prescribing – User guide for Australian prescribers supports prescribers to prescribe medicines by the active ingredient with best practice guidance for specification of brand. Principles are outlined in the user guide to determine when prescribers should consider brand name specification if clinically necessary. Specifying the brand name may be necessary to support safe and quality use of a medicine where consumer harm could result from switching between medicine brands or to ensure prescriber instructions are suitable for the dispensed medicine.
This List of Medicines for Brand Consideration includes medicines prescribers should consider prescribing by brand as well as active ingredient, if clinically necessary for the treatment of their patient. For example, in situations where formulations are not interchangeable due to variations in delivery of the active ingredient, prescribers should consider specification by brand for patient safety.